Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Cancer Res Clin Oncol ; 145(6): 1417-1426, 2019 Jun.
Article in English | MEDLINE | ID: mdl-30923945

ABSTRACT

PURPOSE: Callistemon citrinus (Curtis) Skeels is a shrub native of Australia. In spite of containing an important number of bioactive compounds (1,8-cineole, limonene and α-terpineol) recognized as a potential chemotherapeutic agents, it is only used as an ornamental plant in Mexico. This study investigated the chemopreventive effect of C. citrinus leaves extract on 1,2-dimethylhydrazine (DMH)-induced colon carcinogenesis in rats. METHODS: Twenty-four rats were divided into 3 groups of eight rats. Group 1 served as negative control, groups 2 and 3 were given subcutaneous injections of DMH (65 mg/kg b.w.) twice a week the first 2 weeks, and then one the third week. In addition, group 3 was administrated with leaves extracts (250 mg/kg b.w., orally daily) during the 22 weeks of the experiment. Animals were killed and the presence of colon tumors and aberrant crypt foci (ACF) were scored for number and distribution pattern along the colon. The activity of two-phase II enzymes quinone reductase (QR) and glutathione S-transferase (GST) was determined in the liver and three segments of the colon: proximal, middle and distal. RESULTS: The results show that rats feed with C. citrinus leaves extract significantly reduced the size of tumors, the number of ACF and the crypt multiplicity. Additionally, C. citrinus leaves extract increased or maintained the activity of QR and GST in the different tissues as compared with DHM-treated group (p > 0.05). CONCLUSION: This study demonstrates that Callistemon citrinus extract could have a chemopreventive effect against colon carcinogenesis.


Subject(s)
Colonic Neoplasms/prevention & control , Myrtaceae/chemistry , Plant Extracts/pharmacology , 1,2-Dimethylhydrazine , Aberrant Crypt Foci/chemically induced , Aberrant Crypt Foci/drug therapy , Aberrant Crypt Foci/pathology , Animals , Antineoplastic Agents, Phytogenic/pharmacology , Body Weight/drug effects , Carcinogens , Colonic Neoplasms/chemically induced , Colonic Neoplasms/enzymology , Colonic Neoplasms/pathology , Disease Models, Animal , Male , Random Allocation , Rats , Rats, Wistar
2.
Pharmacology ; 90(5-6): 316-23, 2012.
Article in English | MEDLINE | ID: mdl-23037569

ABSTRACT

The present study investigated the hypothesis that the duration of ovarian hormone deprivation before reintroduction of oestrogen affects the role of oestrogen as a mediator of the contractile function of α(1)-adrenergic receptors. Rats underwent ovariectomy (OVX) or were sham-operated, and the OVX rats were treated with vehicle (corn oil) or 17ß-oestradiol (E(2)) for 5 days either 10, 28 or 60 days after OVX. The OVX increased phenylephrine- and Ca(2+)-induced contractions. Interestingly, the phenylephrine-induced contractions were increased at each of the three time points, whereas the Ca(2+)-induced contractions were only increased in the 60-day group. E(2) had biphasic effects on phenylephrine- and Ca(2+)-induced contractility. Indeed, E(2) increased contractions in the 10-day group and diminished contractions in the other groups (the increased contractions were avoided by verapamil). These results indicate that E(2) controls α(1)-adrenergic receptor-mediated contractility through effects on L-type Ca(2+) channels in a way that depends on the timing in which the treatment with E(2) is initiated.


Subject(s)
Calcium Channels, L-Type/physiology , Estradiol/administration & dosage , Estrogens/administration & dosage , Ovariectomy , Receptors, Adrenergic, alpha-1/physiology , Animals , Aorta, Thoracic/drug effects , Aorta, Thoracic/physiology , Calcium/pharmacology , Calcium Channel Blockers/pharmacology , Female , In Vitro Techniques , Phenylephrine/pharmacology , Rats , Rats, Wistar , Vasoconstriction/drug effects , Vasoconstrictor Agents/pharmacology , Vasodilator Agents , Verapamil/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...